Navigation Links
DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
Date:3/28/2013

New York, NY (PRWEB) March 28, 2013

The medication safety advocates at DrugRisks.com are announcing updated information on the site for patients taking the blood thinner Pradaxa. Researchers presented the American College of Cardiology with a new study this month warning of Pradaxa bleeding risks***, as the number of injury claims continues to grow****.

DrugRisks was designed to reduce the danger of side effects from popular prescription drugs by providing patients with the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide whether they need legal advice.

Information on the resource site shows health experts have disagreed about whether those taking Pradaxa to prevent strokes in atrial fibrillation face higher risks for internal bleeding. The FDA has updated its information to state the drug is as safe as warfarin*.

However, the Institute for Safe Medication Practices recently ranked blood thinners like Pradaxa among the most dangerous drugs available. They also cautioned that patients with bleeding from Pradaxa were nearly 5 times as likely to die than those with bleeding from warfarin**.

Now, DrugRisks has added information showing researchers from the University of Illinois at Chicago presented a study to the American College of Cardiology this month warning that the data used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought***.

Due to the number of patients who have filed a Pradaxa lawsuit over allegations of internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

DrugRisks has also reviewed the latest information from the federal judicial panel on multidistrict litigation, which shows the number of lawsuits alleging serious or fatal internal bleeding has grown from 170 on January 14th to 260 as of March 5, 2013, an increase of over 50%.****

Those affected by internal bleeding after taking Pradaxa are encouraged to speak with a lawyer about their legal options. Since federal drug injury cases can be very specialized, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting
****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_by_District-March-5-2013.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-side-effects/litigation-lawsuit/prweb10579374.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. Approval of Safer Alternative to Pradaxa Delayed by FDA
3. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
4. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
5. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
6. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
7. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
8. DrugRisk Announces New Pradaxa Health Warning From Australia
9. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
10. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
11. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: